SEC Form 4 · accession 0001250853-16-000159
IOVANCE BIOTHERAPEUTICS, INC. · IOVA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Molly Henderson
Officer — CFO
Period of report
Jun 1, 2016
Accepted (ET)
Jun 15, 2016 · 7:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001425205
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF1 | $5.87 | Jun 1, 2016 | A | 150,000 | A | — | Jun 1, 2026 | Common Stock | 150,000 | 150,000 | D |
| Stock OptionF2 | $7.61 | Jun 10, 2016 | A | 50,000 | A | — | Jun 10, 2016 | Common Stock | 50,000 | 50,000 | D |
Explanation of responses
- F1The option will vest as to 50,000 shares on June 1, 2017 and the remaining shares will vest in equal quarterly installments over the next two years after June 1, 2017, provided the Reporting Person is still providing services to the Issuer on the respective dates.
- F2The option will vest as to 16,666 shares on June 10, 2017 and the remaining shares will vest in equal quarterly installments over the next two years after June 10, 2017, provided the Reporting Person is still providing services to the Issuer on the respective dates.